Ipsen to buy French biotech company ImCheck Therapeutics
Ipsen is set to purchase all issued and outstanding shares of the French biotechnology company ImCheck Therapeutics, which specialises in…
All articles by Gullapalli Prasanna
Gullapalli Prasanna
-
-
Ventus and Genentech partner for small-molecule medicine discovery
Ventus Therapeutics has entered a multi-year partnership with Roche’s Genentech for the discovery and optimisation of new small-molecule medicines, utilising…
-
Adcytherix gains $122m to propel ADC development
France-based Adcytherix has completed a Series A funding round, raising €105m ($122m) earmarked for expediting the antibody-drug conjugate (ADC) pipeline…
-
Tubulis closes $361m in Series C to advance cancer treatment
Tubulis has completed a Series C financing round, securing €308m ($361m) that will primarily be directed towards advancing clinical development…
-
BioCryst to buy Astria Therapeutics for $700m in enterprise value
BioCryst Pharmaceuticals has signed a definitive agreement to buy Astria Therapeutics with a mix of cash and stock transactions. The…
-
CIPO grants patent to Palisade Bio’s PALI-2108
The Canadian Intellectual Property Office (CIPO) has awarded Palisade Bio a patent for its ileocolonic-targeted Phosphodiesterase 4, subtype B/D (PDE4…
-
J&J in talks to acquire Protagonist Therapeutics
Johnson & Johnson (J&J) is in discussions to purchase Protagonist Therapeutics, a move that would enhance their current collaboration, as…
-
FDA approves Teva and Medincell’s bipolar I disorder treatment
Teva Pharmaceuticals and Medincell have gained approval from the US Food and Drug Administration (FDA) for Uzedy (risperidone), a once-a-month…
-
Arthrosi gains $153m for development of gout therapy
US-based biotechnology company Arthrosi Therapeutics has completed a series E funding round, amassing $153m which is earmarked to advance the…
-
FDA approves Regeneron’s Libtayo for high-risk CSCC post-surgery
The US Food and Drug Administration (FDA) has granted approval to Regeneron Pharmaceuticals’ fully human monoclonal antibody Libtayo(cemiplimab-rwlc) as an adjuvant…